Asha Anand
Overview
Explore the profile of Asha Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Anand A, Pandi G
Life (Basel)
. 2021 Jan;
11(1).
PMID: 33450961
Regulation of gene expression in any biological system is a complex process with many checkpoints at the transcriptional, post-transcriptional and translational levels. The control mechanism is mediated by various protein...
12.
Garg A, Shah S, Patel K, Shah K, Anand A, Panchal H, et al.
Indian J Hematol Blood Transfus
. 2020 Oct;
36(4):674-679.
PMID: 33100709
Post transplant Hemophagocytic lymphohistiocytosis (HLH) is a form of secondary HLH, which can be either early onset or late onset and is associated with significant morbidity and mortality. With the...
13.
Madabhavi I, Patel A, Modi G, Anand A, Panchal H, Parikh S
J Cancer Res Ther
. 2020 May;
16(1):110-115.
PMID: 32362619
Background: The rationale of this study is to reveal the statistics of pediatric chronic myeloid leukemia (CML) patients. Subjects And Methods: It is a retrospective analysis conducted to assess pediatric...
14.
Saxena M, Madabhavi I, Patel A, Panchal H, Anand A
Int J Hematol Oncol Stem Cell Res
. 2019 Jan;
12(3):197-203.
PMID: 30595822
Metastatic renal cell carcinoma is chemoresistant and radioresistant disease with poor survival historically, but outcome has improved in past decade after introduction of tyrosine kinase inhibitors like sunitinib and sorafenib....
15.
Shah S, Jain P, Shah K, Patel K, Parikh S, Patel A, et al.
Ann Hematol
. 2018 Sep;
98(1):41-46.
PMID: 30173288
Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine A (CsA) is the first-line therapy for acquired aplastic anemia (AA) in those not suitable for bone marrow transplant. Horse ATG...
16.
Parikh S, Goswami P, Anand A, Panchal H, Patel A, Kulkarni R, et al.
Gulf J Oncolog
. 2018 Aug;
1(27):18-23.
PMID: 30145547
Background: The primary objective of this study is to describe clinical and microbiological profile of infections during induction phase of acute myeloid leukemia (AML). Patients And Methods: We reviewed the...
17.
Madabhavi I, Patel A, Sarkar M, Kataria P, Kadakol N, Anand A
J Vasc Nurs
. 2018 Aug;
36(3):149-156.
PMID: 30139453
Effective and reliable venous access is one of the cornerstones of modern medical therapy in oncology. The focus of this prospective observational research is to study the various indications of...
18.
Madabhavi I, Patel A, Modi G, Anand A, Panchal H, Parikh S
J Cancer Res Ther
. 2018 Jun;
14(3):690-693.
PMID: 29893342
Interdigitating dendritic cell tumor/sarcoma (IDCT) is a very rare and aggressive neoplasm arising from antigen-presenting cells. It usually involves lymph nodes, but extranodal sites can also be involved. Because of...
19.
Kukkar S, Panchal H, Anand A
Indian J Cancer
. 2018 May;
54(3):556-559.
PMID: 29798958
Primary neuroendocrine tumors of the thymus are unusual anterior mediastinal tumors with a variable prognosis. A retrospective analysis of five patients with primary neuroendocrine tumors of the thymus admitted to...
20.
Modi G, Madabhavi I, Patel A, Anand A
J Cancer Res Ther
. 2018 Mar;
14(2):462-464.
PMID: 29516942
Alport syndrome is a hereditary disease of the glomerular basement membrane, characterized by the familial occurrence of progressive, hematuric nephropathy with sensorineural deafness. We are reporting here a young adult...